Phase III clinical trials
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials
... Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials Edson D. Moreira Jr, MD, PhD, a Stan L. Block, MD, b Daron Ferris, MD, c Anna R. Giuliano, PhD, d ...
15
Design and Analysis of Phase III Clinical Trials
... Randomized Controlled Trials (Parallel Designs) Parallel Design Each patient receives one and only one treatment in a random fashion. It is simple and easy to implement; applicable to acute conditions. The ...
32
Developing Budgets for Research Projects with a Focus on Phase III Clinical Trials
... Since 1970, we have reduced the mortality rate from cardiovascular disease by 70 percent, at an average cost of $4 per person a year for cardiovascular research. With cardiovascular disease, the results have been ...
45
Reporting quality of abstracts in phase III clinical trials of systemic therapy in metastatic solid malignancies
... randomized phase III metastatic solid tumor trials and further standardization of reporting may be necessary for other types of trials and disease ...
8
Dose selection in seamless phase II/III clinical trials based on efficacy and toxicity
... these trials require combining evidence from phase II stage and the phase III stage which can be done using the group sequential technique or by combination tests so that these methods of ...
152
Phase III trials in oncology
... in clinical trials for optimum assessment of treatments, monitoring and follow-up, and conse- quently better survival and quality of life compared with routine manage- ...Randomised phase III ...
7
Hepatic profile analyses of tipranavir in Phase II and III clinical trials
... subsequent clinical hepatic events because the majority of patients remained ...RESIST trials, which enrolled more than 1400 treat- ment-experienced patients ...these trials has indicated that TPV/r ...
11
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility
... 5. Discussion In drug development, the need to reduce the cost and time taken to test new treatments has led to the use of ASDs. ASDs combine several phases of a clinical development program into a single trial. ...
19
Sequential Design of Phase II-III Cancer Trials
... most clinical investigators are aware of the “unreliability of data” obtained in small single-arm phase II cancer trials, they cannot commit the resources needed for “comparative controlled ...
40
Three-Stage Phase II Clinical Trials
... Phase II trials obtain initial estimates of the degree of treatment activity. A patient’s response may be measured by the decrease in the size of a tumor. For example, a patient may be considered to have ...
7
Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review
... in phase III randomized trials (RCTs) of adjuvant treatments in early stage breast cancer with disease free survival as primary endpoint of the study, in order to verify if a similar variance exists ...
12
Phase III Soft Tissue Sarcoma Trials: Success or Failure?
... of phase III drug trials performed in advanced STS over the past 30 years have recruited cohorts consisting of many different disease ...included trials recruited from a single specified ...
16
Advanced Designs of Cancer Phase I and Phase II Clinical Trials
... optimal sample size. In the other word, during the process of pursuing an optimal or minimal sample size, it may sacrifice the capability to detect or filter out the confounding results. Except the above analysis of the ...
139
Meta analysis of randomized phase II trials to inform subsequent phase III decisions
... bias, Phase II trials may be more prone to bias in their design, execu- tion, and analysis, which could also cause optimistic meta-analysis results for Phase II ...Therefore clinical guidance ...
15
Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
... life. 1 2 RA is characterised by inflammation of the artic- ular synovium leading to deformity, progressive disability and ultimately destruction of joints. The current guidelines of both the European League against ...
10
Efficacy of intravenous tigecycline in patients with <em>Acinetobacter </em>complex infections: results from 14 Phase III and Phase IV clinical trials
... The clinical trial data discussed in this paper could be hypothesis- generating for a larger and well-controlled systematic ...controlled clinical trial data that are presently ...described clinical ...
17
Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder
... Acknowledgments Sue Cooper from Envision Scientific Solutions provided medical writing assistance for this work, which was sup- ported by Astellas. Conflict of interest Chris Chapple is a Consultant or Researcher for ...
8
A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short term endpoints
... for phase II/III designs concerns the question of how to incorporate early endpoint data into the treatment selection part of such a ...sequential clinical trials comparing a single ...
23
Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials
... 3.3. Capecitabine In the phase III BILCAP trial, 447 patients with BTC were rando- mized to receive adjuvant capecitabine or observation after a complete surgical resection.( Primrose et al., 2019 ) In the ...
9
Estimation following a phase II/III clinical trial
... methodology and how it can be applied in real trials (joint workshops / meetings / working groups etc) • Adaptive seamless clinical trial designs (in the. broadest sense) have proved t[r] ...
25